The invention belongs to novel medical application of known medicines, and particularly relates to application of cyanocobalamine in preparation of a
Brucella bacteriostatic agent. In the specific embodiment of the invention, firstly, four main chemical forms (
cyanocobalamin, hydroxycobalamin, methyl
cobalamin and
adenosine cobalamin) of the
vitamin B12 are added into a
Brucella culture medium to culture
Brucella, and experimental results show that the four forms of
vitamin B12 can obviously inhibit the growth of Brucella; wherein the inhibition effect of the cyanocobalamine is most obvious. Then,
cyanocobalamin with different concentrations is added into a Brucella culture medium to culture Brucella, and the experimental result shows that the CFU of the Brucella is obviously reduced along with the increase of the concentration of the
cyanocobalamin. Similarly, cyanocobalamine can also significantly inhibit
intracellular proliferation of Brucella at the
cellular level. The cyanocobalamine is a clinically common
medicine, and no
side effect is reported at present, so that the cyanocobalamine can be used for preparing the Brucella
bacteriostatic agent and is clinically used for preventing and treating Brucella diseases.